The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lol 7.2p I might break even, I think your alarm is going off
MGC keeps driving forward with regular news. Wont be long before the analysts prediction of 7.2p in 2022 translates into reality for 2023,their opinion hasnt changed !
More encouraging news from MGC regarding the successful completion of its CimetrA™ pre-clinical trial. This is yet another big step forward for the company. Big pharma won't want to miss out on this soon. See results below. We operate in a highly acquisitive multi billion sector. Watch this space for licencing or a takeover of MGC in due course.
* "important milestone moment for the Company", as it continues to progress CimetrATM along the mandated clinical pathway.
* "In pre-clinical and clinical trials CimetrATM has demonstrated anti-inflammatory and immunomodulating effects, and can be designed for multiple therapeutic applications" .
.
* "Preclinical and clinical results to date have demonstrated CimetrATM's mechanism of action as an anti-inflammatory and immunomodulatory agent which is effective in the prevention of severe inflammation by its control of increased Cytokine production resulting from an infection of the different variants of SARS-CoV-2 (the virus responsible for COVID-19); and which is the forerunner of a Cytokine Storm, which is believed to be the main reason for mortality in severe COVID-19 patients".
* The results of this study are a critical step in advancing MGC's submission to the FDA, and for the final approval of CimetrATM as an Investigational New Drug in the US."
Good luck, Brighty
... I agree. IMO it shows they can be taken seriously. Wish more young companies were like them.
Great way to start the year mgc, resignations, wage cuts, one thinks a placing is trying to be avoided here.
Here it is
Another new low
Another new low coming
There is a huge disparity between what is printed and what happens in practice. Most doctors are reluctant to prescribe cannabis derived products... Why? Answers on a postcard.... No MGC products though...
Patience is essential. What else can you be in a market like this? . MGC has as much chance as any other innovative company of making good. It will have its ups and downs but based on all the positive progress during difficult economic times, in my opinion its super- likely to increase in value over time.
These white papers you read, are they attached to a roll in the privy? Because it sounds like sxxxe to me... Honestly... White papers?? I think you take white powders mate... this dog of a share is doomed....
Is that I can write this loss off against my tax bill lol
Not at all. My opinion based on the research and white papers I have read …
Only 8 posts.... And you have a huge loss.... Sounds like a new ramping account to me...
This will go boom in the next 6-12 months.
I’m holding at a big loss and no plans to sell …
If I had any spare cash I’d buy even more …
Be bold for Gold !
back to the base
https://www.proactiveinvestors.co.uk/companies/news/1000613/mgc-pharmaceuticals-delivers-its-largest-ever-order-1000613.html
cracking chart that aswelll....0.70,looks to be the end of the downtrend..imo
55 rodents
Of Mice & Men
MGC has issued an excellent update today re the pre-clinical trial of CimetrA . Highlights below. Big pharmaceutical companies will be monitoring developments here. They won't want to miss out once this gets US Food and Drug Administration approval. As others have stated recently on this BB it's hold for gold with MGC. This is another significant milestone just announced today.
Key Highlights:
* A pre-clinical study has now been completed on a model of cytokine storm in rodents using the CimetrA™ formulation, and has demonstrated an anti-inflammatory effect in three different dosages of treatments.
* The study results demonstrate CimetrA™'s effect on the anti-inflammatory and pro-inflammatory cytokines and chemokines which support the previous anti-inflammatory results of CimetrA™.
* The study results will form part of the US Food and Drug Administration (FDA) application to register CimetrA™ as an Investigational New Drug (IND), and is a critical milestone in the process of drug registration.
Good luck, Brighty
I cant believe that as 2023 approaches people are still listening to that haji taz guy lmfao
Oz was a believer but eventually he saw the light...this is Russian roulette.... Even an American order has not ignited it.... Smell the coffee boys!
I nearly did what you did but I’m pretty sure this will grow nicely over the next few years …I’m holding for GOLD
Wolf. I'm of the same opinion dont know what your idear of a few years are but I think I'll give it two to start with . My average is 2.9 hope to add more at these low prices to get average down a bit more then just wait. I do think this one will come good just needs time
Just need to have the stomach for this one. All the bottle jobs like Mornington-oz have left the building. I'm sitting on this puppy for a few years. Slowly slowly catchy monkey!